Skip to main content

Linaclotide to Lead the Global Chronic Idiopathic Constipation Drugs Market at a CAGR over 7% during 2016 - 2022: Credence Research

The latest market report published by Credence Research, Inc. “Global Chronic Idiopathic Constipation (CIC) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the chronic idiopathic constipation (CIC) drugs market was valued at USD 1675.4 Mn in 2015, and is expected to reach USD 2570.8 Mn by 2022, expanding at a CAGR of 6.4% from 2016 to 2022; where Europe has the largest market share.
Market Insights
Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder. The currently available treatment options, both prescription based and OTC have demonstrated limited efficacy in a considerable set of patients. Thus there is a major demand for more effective medications for the treatment of CIC. Linaclotide is a secretagogue and has novel action mechanism; it has low oral bioavailability and has demonstrated the least systemic side effects. Through several clinical trials, Linaclotide has demonstrated greater efficacy in treating both CIC and irritable bowel syndrome induced constipation.
Currently North America is the largest regional market for CIC drugs at a market share of approximately 50%. It is also expected that the region will progress at the fastest CAGR of above 8% during the forecast period. Higher awareness among physicians and patient population significantly contribute the market growth in the region. Earliest commercialization of the drug in the US also adds up to the high demand of the drug in North America market. On the other hand, gradual introduction of Linaclotide in other developing markets will facilitate market growth in Asia Pacific market. China, Japan, Australia and India are the major national markets that are expected to give highest revenue contributions to the Asia Pacific CIC drugs market. Also, supporting the established fact of correlation between age and risk of CIC, it is reported that China and Japan will be the largest national markets for CIC drugs in Asia Pacific.
Overall, the CIC drugs market is open for further innovations, anticipating introduction of novel therapeutic options in the global market. Intensive research and development activities undertaken by the major market players indicate further competition in the market in the next ten years.
Chapter 1 Preface
1.1 Report Scope and Description
1.2 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Global CIC Drugs Market Analysis
3.1 CIC Drugs Market Overview
3.2 Market Inclination Insights
3.3 Attractive Investment Proposition, 2015
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Adverse health effects from modern dietary habits
3.4.1.2 Cancer or other systematic disease
3.4.1.3 Increasing geriatric population
3.4.1.4 Better and effective drugs in pipeline
3.4.1.5 Increasing constipation problems as a side-effect frequently prescribed medicines
3.4.2 Restraints
3.4.2.1 Surgical treatments
3.4.2.2 Unawareness and Ignorance among people
3.4.2.3 Side-effects of the chronic idiopathic constipation drugs
3.4.3 Opportunities
3.4.3.1 Emerging APAC market
3.4.3.2 High unmet needs
3.5 Attractive Investment Proposition, 2015
3.6 Market Positioning of Key CIC Drugs Manufacturers
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
Labels:

Comments

Post a Comment

Popular posts from this blog

Algae Products Market Key Growth Factors and Industry Analysis 2023: Credence Research

According to a new market report published by Credence Research “ Algae Products Market  - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the algae products market is expected to reach US$ 44.7 Bn by 2023, expanding at a CAGR of more than 5.0% from 2016 to 2023. Browse the full report at  http://www.credenceresearch.com/report/algae-products-market Market Insights: Algae are a diverse group of photosynthetic organisms which are not closely related and hence are known to be polyphyletic. They are plats which range from microalgae to macro algae. Algae are grown using water resources such as sea and waste water which are not suitable for growing agricultural crops. Microalgae grow using sunlight i.e. photosynthesis, by converting sunlight, CO2 and nutrients such as phosphorus and nitrogen into biomass. This growth is also known as autotrophic growth. Some algae can grow in the dark using sugar starch or by combining both the growth modes. Based on applica
Post a Comment
Read more

Global Monoethylene Glycol (MEG) Market for Polyethylene Terephthalate (PET), Polyester Fiber, Coolant & Antifreeze and Other Applications- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2021: Credence Research

According to a new market report published by Credence Research “ Monoethylene Glycol (MEG) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2021,” the monoethylene glycol (MEG) market is expected to reach over US$ 37.5 Bn by 2022, expanding at a CAGR of 6.0% from 2016 to 2022. Browse the full report at  http://www.credenceresearch.com/report/monoethylene-glycol-meg-market Market Insights Monoethylene glycol is an odorless, colorless and barely viscous liquid which is miscible in alcohols, water, aldehydes and many other organic compounds. Monoethylene glycol is one of the key commercially available glycols. The coproducts such as diethylene glycol and triethylene glycol are obtained in the manufacturing process of MEG from ethylene oxide. End-user industries such as textile and packaging among others are the major consumers of monoethylene glycol in the market. Monoethylene glycol is primarily used as raw material in production of polyethylene t
Post a Comment
Read more

Global 3D Printing in Healthcare Market Growth, Future Prospects and Competitive Analysis 2023: Credence Research

According to a new market research report published by Credence Research “ 3D Printing in Healthcare (Polyjet, Stereolithography (SL), Fused Deposition Modelling (FDM), Electron Beam Melting, Selective Laser Sintering (SLS), Others) Market - Growth, Share, Opportunities, Competitive Analysis and Forecast 2016 - 2023”, the global healthcare 3D printing market is estimated to expand with a CAGR of 17.5% from 2016 to 2023. The complete report is available at   http://www.credenceresearch.com/report/3d-printing-in-healthcare-market Market Insights: 3D printing, also called as additive manufacturing, refers to a process of making three-dimensional (3D) solid objects using a digital model. In 3D printing, the object is prepared by placing down successive layers of material. Since the introduction of 3D printing technology in 1984, the technology is steadily becoming popular across various applications such as jewelry, consumer goods, industrial design, aerospace, construction, automo
Post a Comment
Read more